New Journal for ImmunoTherapy of Cancer article: Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinoma bit.ly/4lcxHLC ‪ @riyuesunnybao.bsky.social @pancpathologist.bsky.social ‪ @zervanto.bsky.social @jasonlukemd.bsky.social #JITC #cancer #MedSky

🔥 Great discussion at the in person meeting of the GLOBAL GUIDELINES FOR CYSTIC TUMORS OF THE PANCREAS expected to be released 🔜 stay tuned! @letswinpc.org #HPBSky

A huge majority of Americans (77%) oppose the cuts to medical research that the current administration has made. (Source: Wash. Post/ABC/Ipsos poll)

A little late, but what a wonderful time supporting #PancreaticCancer research at @pancan.bsky.social purplestride in Pittsburgh. @news.upmc.com @upmc.com @upmchillmancc.bsky.social

If you or someone you love has been diagnosed with #pancreaticcancer, you’re not alone — we’re here to help. 💜 Our educational packets include essential resources to help you navigate next steps. Access these materials digitally 🖥️ or have them mailed to you 📬 by visiting pcan.at/skpmuj.

This is catastrophic for pancreatic cancer patients

In HER2-positive early #breastcancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival Check out the full story 👇 www.curetoday.com/view/kadcyla...

Our incredible Team PanCAN runners are lacing up for the LA Marathon and Charity Half Marathon, and the United Airlines NYC Half Marathon today! 💜🏃‍♂️ They’ve spent months training and fundraising to make a difference for pancreatic cancer patients. Let’s show them some love in the comments!

Serous Cystadenoma HOP with Vascular Map

💥 A Stellar episode of our virtual meeting on pancreas topic.. this time IPMN 🍇 !!! 🚨 Integrating molecular testing to the evaluation of Pancreatic Cyst with the great @pancpathologist.bsky.social 🇺🇸 @upmc.bsky.social Thank you, Aatur Singhi, for such a Christmas gift!!! 🎄 youtu.be/fF7HcPCqiwk

Benign Pancreatic Tumors Read more here: ctisus.com/learning/fea...

More data on role of ATRX/DAXX loss for surgery in pancreas #NETs 👥116 PNETs in 🇯🇵 🧬11% DAXX & 7% ATRX loss 👉🏻intratumoral heterogeneity in 1/3 ⬇️RFS with ATRX/DAXX loss Should it be done routinely on all PNETs? 🔗 pubmed.ncbi.nlm.nih.gov/38909708/ #NETsSky #HPBSky #SurgSky #PancSky

PNET: CT Findings ctisus.com/learning/fea...

Pancreatic Paraganglioma: CT Findings ctisus.com/learning/fea...

Is the other ALT (alternative lengthening of telomeres) ready for use in pNETs..? I think so, especially for prognostication after resection. Chromogenic ISH (CISH) easier to implement than FISH. Excellent stuff from Chris Heaphy, Aatur Singhi et al. www.sciencedirect.com/science/arti...